Motley Fool
Why Sorrento Therapeutics Stock Gained 29% Last Month
Shares of biopharma stock Sorrento Therapeutics (NASDAQ: SRNE) rallied 28.9% in June, according to numbers provided by S&P Global Market Intelligence. Although the stock was already primed for bullishness following a steep pullback earlier in the year, a pair of drug trial updates juiced the brewing bounce. There was no catalyst for the bounce that took shape in May. Bullish headlines didn't start materializing again until last month, first when the company announced a collaboration with U.S. Navy's medical research arm to work on COVID-19 therapies, and then on the heels of news that it has been given regulatory approval by Mexico to sell COVID rapid tests in that country.
"share" - Google News
July 08, 2021 at 10:51PM
https://ift.tt/2SWIPov
Melco Resorts Adopts Share Purchase and Award Program To Recognize Employees - Yahoo Finance
"share" - Google News
https://ift.tt/2VXQsKd
https://ift.tt/3d2Wjnc
Bagikan Berita Ini
0 Response to "Melco Resorts Adopts Share Purchase and Award Program To Recognize Employees - Yahoo Finance"
Post a Comment